Dimensional Fund Advisors
CSBR icon

Dimensional Fund Advisors’s Champions Oncology CSBR Stock Holding History

Dimensional Fund Advisors’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$138K Sell
23,973
-1,381
-5% -$8.77K ﹤0.01% 3097
2025
Q4 		$175K Buy
25,354
+1,652
+7% +$11K ﹤0.01% 3101
2025
Q3 		$153K Buy
23,702
+1,297
+6% +$9.14K ﹤0.01% 3153
2025
Q2 		$165K Buy
+22,405
New +$158K ﹤0.01% 3138
2024
Q1 		– Sell
-26,839
Closed -$145K – 3399
2023
Q4 		$145K Sell
26,839
-32,241
-55% -$180K ﹤0.01% 3242
2023
Q3 		$367K Sell
59,080
-28,591
-33% -$181K ﹤0.01% 3106
2023
Q2 		$551K Sell
87,671
-28,620
-25% -$148K ﹤0.01% 3043
2023
Q1 		$467K Sell
116,291
-5,514
-5% -$23.6K ﹤0.01% 3042
2022
Q4 		$550 Hold
121,805
– – ﹤0.01% 3024
2022
Q3 		$914K Buy
121,805
+8,462
+7% +$70.8K ﹤0.01% 2901
2022
Q2 		$917K Buy
113,343
+1,424
+1% +$10.9K ﹤0.01% 2934
2022
Q1 		$910K Buy
111,919
+1,300
+1% +$10.4K ﹤0.01% 3016
2021
Q4 		$885K Sell
110,619
-9,283
-8% -$85.5K ﹤0.01% 3056
2021
Q3 		$1.22M Sell
119,902
-10,753
-8% -$109K ﹤0.01% 2998
2021
Q2 		$1.34M Buy
130,655
+2,362
+2% +$23.9K ﹤0.01% 2968
2021
Q1 		$1.45M Sell
128,293
-3,220
-2% -$37.4K ﹤0.01% 2929
2020
Q4 		$1.42M Sell
131,513
-956
-0.7% -$9.86K ﹤0.01% 2899
2020
Q3 		$1.23M Sell
132,469
-1,200
-0.9% -$10.7K ﹤0.01% 2878
2020
Q2 		$1.28M Buy
133,669
+416
+0.3% +$3.55K ﹤0.01% 2875
2020
Q1 		$986K Hold
133,253
– – ﹤0.01% 2895
2019
Q4 		$1.11M Sell
133,253
-22,245
-14% -$137K ﹤0.01% 2989
2019
Q3 		$879K Hold
155,498
– – ﹤0.01% 3034
2019
Q2 		$1.22M Buy
155,498
+22,328
+17% +$196K ﹤0.01% 3015
2019
Q1 		$1.3M Buy
133,170
+63,727
+92% +$635K ﹤0.01% 2978
2018
Q4 		$542K Buy
+69,443
New +$798K ﹤0.01% 3131

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors's CSBR Position: Q1 2026 in Review

Dimensional Fund Advisors reduced its Champions Oncology (CSBR) stake by 5.4% in Q1 2026, selling an estimated $8.77K and leaving 23,973 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #3097.

Dimensional Fund Advisors first reported a position in CSBR in Q4 2018 and has held it in 25 quarters since. The position peaked at $1.45M in Q1 2021. 25 funds tracked by Wall St. Rank hold CSBR as of Q1 2026.

  • Dimensional Fund Advisors held 23,973 shares of Champions Oncology worth $138K as of Q1 2026.
  • Dimensional Fund Advisors sold 1,381 Champions Oncology shares in Q1 2026, an estimated $8.77K.
  • Champions Oncology made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #3097 holding.
  • Dimensional Fund Advisors first reported a position in Champions Oncology in Q4 2018 and has held it in 25 quarters since.
  • Dimensional Fund Advisors's Champions Oncology position peaked at $1.45M in Q1 2021.
  • 25 funds tracked by Wall St. Rank held Champions Oncology as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.